HIV and Cardiovascular Disease Burden in Young Adults (18-25 years): A Review of Current Evidence

Edith D Majonga1,2, Anoop S V Shah3

  • 1Biomedical Research and Training Institute, Harare, Zimbabwe. Edith.Majonga@lshtm.ac.uk.

PubMed

Insights

Cardiovascular disease (CVD) in youth with HIV is driven by non-atherosclerotic mechanisms, not just traditional atherosclerosis. More research is needed to understand and reduce this burden.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Young people living with HIV (PLWH) face a growing burden of cardiovascular disease (CVD).
  • Traditional risk factors for CVD may not fully explain the pathology in this population.
  • Understanding HIV-associated CVD mechanisms in youth is critical for effective management.

Purpose of the Study:

  • To synthesize current evidence on the cardiovascular disease burden in young people living with HIV.
  • To explore myocardial and vascular pathology in HIV-associated CVD among youth.
  • To evaluate advanced imaging techniques and identify knowledge gaps in HIV-associated CVD mechanisms.

Main Methods:

  • Systematic review of current scientific literature.
  • Analysis of myocardial and vascular pathology in youth with HIV.
  • Evaluation of advanced imaging modalities for detecting subclinical CVD.

Main Results:

  • HIV-associated CVD in youth appears driven by non-atherosclerotic mechanisms like myocardial injury and fibrosis.
  • Subclinical myocardial changes, including increased left ventricular mass and reduced strain, are observed via imaging.
  • Longitudinal data and multimodal imaging are scarce, especially in African settings.

Conclusions:

  • The current understanding of HIV-associated CVD in youth may be incomplete, with atherosclerosis not being the sole driver.
  • There is a critical need for longitudinal, mechanistic research, particularly in high-burden regions.
  • Developing tailored clinical strategies and policy interventions is essential to reduce long-term cardiovascular morbidity in young PLWH.
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
389
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
476
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
426
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
584
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
282
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
322